BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T120000
DTEND;TZID=America/Los_Angeles:20260617T130000
DTSTAMP:20260617T215551
CREATED:20260609T175230Z
LAST-MODIFIED:20260609T175230Z
UID:10001100-1781697600-1781701200@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences – Virtual
DESCRIPTION:​Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​This is a 60-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working AI agent around an example provided. No coding experience required. \n​Be ready with your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T090000
DTEND;TZID=America/Los_Angeles:20260617T100000
DTSTAMP:20260617T215551
CREATED:20260603T171823Z
LAST-MODIFIED:20260603T171823Z
UID:10001096-1781686800-1781690400@www.califesciences.org
SUMMARY:From Breakthrough to Bedside: Aligning Regulatory Strategy\, Clinical Evidence and Commercialization in Diagnostics
DESCRIPTION:This panel will examine how diagnostics innovators can effectively move from concept to market adoption. The discussion will cover critical intersections between regulatory strategy\, clinical validation and commercialization\, including FDA pathways\, clinical study design and how to position programs for investment and scale. \nSpeakers include:\n› Sarah Melaney\, Pillsbury Partner (Moderator)\n› Steven Green\, Pillsbury Partner (Panelist)\n› Joen Johansen\, President & CEO of MDC Associates (Panelist)\n› Michele Colucci\, Founding Managing Partner of DigitalDX (Panelist) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T113000
DTEND;TZID=America/Los_Angeles:20260617T170000
DTSTAMP:20260617T215551
CREATED:20260609T155617Z
LAST-MODIFIED:20260609T155617Z
UID:10001098-1781609400-1781715600@www.califesciences.org
SUMMARY:Accelerating Advanced Therapies
DESCRIPTION:Progress in advanced therapies isn’t achieved in isolation. It’s shaped through shared expertise\, practical experience\, and meaningful collaboration. \nJoin Cytiva specialists and industry peers on June 16 & 17th for Accelerating Advanced Therapies\, an immersive\, in-person event centered on partnership\, insight\, and hands-on innovation across genomic medicine development and manufacturing. \nThrough practical learning and real-world discussion\, this event moves beyond theory to help you drive progress in an increasingly complex genomic medicine landscape. \n\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-advanced-therapies/
LOCATION:10300 Campus Point Dr\, 10300 Campus Point Dr\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T100000
DTEND;TZID=America/Los_Angeles:20260616T110000
DTSTAMP:20260617T215551
CREATED:20260526T160015Z
LAST-MODIFIED:20260526T160015Z
UID:10001092-1781604000-1781607600@www.califesciences.org
SUMMARY:Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
DESCRIPTION:As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance\, the need for efficient and scalable development solutions continues to grow. \nJoin our webinar to explore how AI-enabled protein engineering\, optimized reagents\, and advanced assay platforms can support translational research\, improve reproducibility\, streamline manufacturing\, and accelerate next-generation cancer therapeutics development. \nKey highlights include:\n🔹 AI-powered protein engineering and advanced assay solutions\n🔹 Tools to improve protein interaction studies\, reproducibility\, and translational research\n🔹 Strategies to accelerate next-generation cancer therapeutic development \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T170000
DTEND;TZID=America/Los_Angeles:20260610T200000
DTSTAMP:20260617T215551
CREATED:20260601T225930Z
LAST-MODIFIED:20260601T225930Z
UID:10001095-1781110800-1781121600@www.califesciences.org
SUMMARY:Beyond the Red Tape: Scaling Connected Health in 2026
DESCRIPTION:As healthcare moves toward proactive\, preventive\, and AI-enabled care models\, the regulatory boundary between “wellness” and “medical device” has been fundamentally redefined. This event brings together leading experts in Regulatory Affairs\, Quality\, Connected Health\, and Digital Health to discuss how organizations can successfully scale connected ecosystems in this new regulatory era. \nKey topics include:\n💡 The 2026 FDA regulatory changes impacting Connected Health and Clinical Decision Support (CDS)\n💡 How companies are navigating the evolving “wellness vs. medical device” boundary\n💡 AI-enabled sensors\, remote monitoring\, and digital health ecosystems\n💡 Using Predetermined Change Control Plans (PCCPs) for AI and software lifecycle management\n💡 Strategies to accelerate innovation while maintaining compliance\n💡 Data validation and regulatory considerations for next-generation connected platforms \n🎤 Featured Speakers:\nRitam Priya — Principal\, Novarum MDRQ Consulting\nWalt Cecka — Medical Technology Fellow\, Triple Ring\nYusi Liu\, RAC.\, SVP of RA and QA\, BioIntelliSense Inc.\nJeanne Zhang\, Principal Regulatory Affairs Specialist\, MiniMed\nAarti Shukla\, M.S.Rsc\, RAC\, Regulatory Affairs\, Roche \n🤝 The evening will also include networking opportunities and an exclusive facility tour of Triple Ring Technologies. \nWhether you work in Regulatory Affairs\, Quality\, Digital Health\, MedTech\, AI\, Software\, or Connected Devices\, this is a conversation you won’t want to miss. \nHosted by:
URL:https://www.califesciences.org/event/beyond-the-red-tape-scaling-connected-health-in-2026/
LOCATION:Triple Ring Technologies\, 39655 Eureka Dr\, Newark\, CA\, 94560\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T170000
DTEND;TZID=America/Los_Angeles:20260610T193000
DTSTAMP:20260617T215551
CREATED:20260609T174947Z
LAST-MODIFIED:20260609T174947Z
UID:10001099-1781110800-1781119800@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences
DESCRIPTION:Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​This is a 90-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working AI agent around a task from your own workflow. No coding experience required. \n​Bring a laptop\, your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \n​Agenda: \n​5:00-5:30p: Sign in \n​5:30-7:00p: Workshop \n​7:00-7:30p: Networking (NA beverages and light snacks) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences/
LOCATION:San Francisco\, San Francisco\, CA\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T114500
DTEND;TZID=America/Los_Angeles:20260610T130000
DTSTAMP:20260617T215551
CREATED:20260601T225608Z
LAST-MODIFIED:20260601T225608Z
UID:10001094-1781091900-1781096400@www.califesciences.org
SUMMARY:How to Compete for $4 Billion in Newly Reauthorized SBIR/STTR Funds
DESCRIPTION:The recent reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program introduces exciting new opportunities along with evolving requirements and shifting priorities. \n​For innovators aiming to compete successfully in this new SBIR/STTR landscape\, a thorough understanding of the reauthorization provisions is essential. \n​Join Eva Garland Consulting’s Scientific Grants Expert\, Dr. Chelcie Heaney\, as she provides a practical overview of the latest SBIR/STTR reauthorization and what it means for applicants targeting the National Institutes of Health and National Science Foundation. Attendees will gain insight into key program updates\, emerging compliance considerations\, and an expert perspective on how to remain competitive in one of the nation’s most valuable non-dilutive funding programs. \n​Lunch will be provided\, and attendees will receive complimentary copies of EGC’s best-selling books on winning SBIR/STTR grants. \n​Agenda: \n\n​11:45 AM – 12:00 PM Arrival and Lunch\n​12:00 PM – 12:30 PM Presentation\n12:30 PM – 1:00 PM Q & A and Networking\n\n​About Dr. Chelcie Heaney: \n​Dr. Heaney is a Senior Scientific Consultant at Eva Garland Consulting. She is an expert in securing non-dilutive funding for life science companies\, with a focus in technology assessment\, product development\, proposal preparation\, gap identification\, and strategic planning. She has contributed to hundreds of grant proposals across Federal Agencies including NIH\, NSF\, DoD\, NASA\, ARPA-H\, and the VA\, helping to secure over $100M in funding for life science companies. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-compete-for-4-billion-in-newly-reauthorized-sbir-sttr-funds/
LOCATION:University Lab Partners\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T110000
DTEND;TZID=America/Los_Angeles:20260610T140000
DTSTAMP:20260617T215551
CREATED:20260520T223016Z
LAST-MODIFIED:20260520T223016Z
UID:10001089-1781089200-1781100000@www.califesciences.org
SUMMARY:MBC BioLabs Summer Life Science Vendor’s Showcase
DESCRIPTION:Join us for our Summer Life Science Vendor Showcase\, bringing together innovative scientific and business solutions tailored for early-stage biotech teams. Meet industry experts\, explore new technologies\, and discover tools that can accelerate your work at MBC BioLabs. \nWhat to Expect: \n\n​Discover Solutions for Startups — Explore tools and services designed to support drug discovery\, molecular biology\, genomics\, instrumentation\, operational efficiency\, and company growth.\nLunch Included — Pick up your lunch ticket at check-in and enjoy a meal while you explore the showcase.\nMeet New Partners & Build Your Network — Connect with leading vendors who offer cutting-edge technologies and services to strengthen your R&D pipeline.\n\n​This showcase is ideal for: \n\nFounders and early-stage biotech teams\nResearch associates and bench scientists\nPlatform\, screening\, and discovery scientists\n​Operations\, lab managers\, and procurement teams\nAnyone looking to evaluate new tools\, technologies\, or service providers that support R&D and company growth\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mbc-biolabs-summer-life-science-vendors-showcase/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260609T090000
DTEND;TZID=America/Los_Angeles:20260610T160000
DTSTAMP:20260617T215551
CREATED:20260422T182437Z
LAST-MODIFIED:20260422T182507Z
UID:10001070-1780995600-1781107200@www.califesciences.org
SUMMARY:2-Day Hands-on Lyophilization Development & Analysis Workshop
DESCRIPTION:A practical guide to lyophilization formulation\, cycle development and analytical characterization\n\nBook before May 1st and save $500 \n\n2-Day Intensive Laboratory Training | Small Group Format | Certificate of Completion \nThis immersive program guides participants through the complete lyophilization process\, from formulation and thermal analysis to cycle development\, optimization\, and troubleshooting\, in a real working CDMO facility in Carlsbad\, California. Unlike training center environments\, attendees work alongside the same team and equipment used in active commercial production. \nTaught by Dr. Kevin Ward\, R&D Director at Biopharma Group for 26 years and practicing lyophilization since 1993. Kevin and his team have worked on over 5\,000 projects for more than 500 clients across the globe and run more than 400 training courses. \nWhat you’ll learn: \n\nApply thermal characterization (DSC\,impedance analysis) directly to cycle design; understand how to generate and interpret the data necessary to build a stable lyo cycle\nTranslate that analytical data into practical cycle development steps; understand how freezing\, annealing\, primary and secondary drying combine to give you a reliable and consistent end product\nBuild and run freeze-drying cycles based on real-time PAT data\nTroubleshoot problematic cycles with structured strategies such as: What has gone wrong? How do you fix it?\nEvaluate lyophilization cake appearance and identify defects\nPerform post-lyophilization analysis: moisture content\, thermal properties\, mechanical performance\nTransfer cycles between lyophilizers and scaling up from research to production.\n\nThis is a hands-on program\, not a lecture series. Concepts are explored through direct\, practical involvement in our working facility and guided by our expert team every step of the way. Certificate of completion provided. \nView our overview brochure to discover more» \nHosted by:
URL:https://www.califesciences.org/event/hands-on-lyophilization-development-analysis-workshop/
LOCATION:2270 Camino Vida Roble #K\, 2270 Camino Vida Roble #K\, Carlsbad\, CA\, 92104\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T110000
DTEND;TZID=America/New_York:20260603T130000
DTSTAMP:20260617T215551
CREATED:20260521T164804Z
LAST-MODIFIED:20260521T164804Z
UID:10001091-1780484400-1780491600@www.califesciences.org
SUMMARY:Endpoints at #ASCO26
DESCRIPTION:ASCO is where oncology pipelines get stress-tested in front of the entire world. Readouts can make or break big pharma strategies and reshape treatment paradigms overnight. Join Endpoints News and leading oncology researchers as we break down the science and data worth a second look. We’re examining new readouts\, unpacking the most anticipated trials on deck and discussing the biggest themes in cancer research. \nAgenda\n11:00 AM – 11:25 AM ET: In conversation with Jeff Legos\nWe’ll sit down with Pfizer’s Chief Oncology Officer for an update after his first year on the job\, and how he’s thinking through the pharma’s cancer pipeline. \n11:30 AM – 11:55 AM ET: Catching KRAS\nFor decades\, KRAS was an obvious target for cancer treatments. And for decades\, it seemed like an undruggable target. But that started to change with the first approved KRAS therapies. Research took off\, and now\, new data on pancreatic cancer suggest a potential breakthrough. Join pioneers in the space for a conversation on recent progress and where the work goes next. \n12:00 PM – 12:30 PM ET: Delivering excellence\, close to home\nCommunity oncology is the backbone of cancer care in the U.S.\, treating the majority of patients and ensuring care is delivered close to home in communities across the country. This panel will explore how community oncologists are navigating increasing clinical complexity while continuing to deliver high-quality\, patient-centered care. The session will highlight what is working today — and what needs to evolve — to support and strengthen community oncology as a foundational component of the cancer care ecosystem. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/endpoints-at-asco26/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/endpoints-at-asco26/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T093000
DTEND;TZID=America/Los_Angeles:20260527T120000
DTSTAMP:20260617T215551
CREATED:20260407T201911Z
LAST-MODIFIED:20260407T201911Z
UID:10001057-1779874200-1779883200@www.califesciences.org
SUMMARY:Deciphering and re-engineering the immune response to cancer
DESCRIPTION:Event Agenda\n9:30 AM – Vendor Show/Guest Check-In \n10:30 AM – Vancouver-PBSS Welcome \n10:45 AM – Deciphering and re-engineering the immune response to cancer \n11:45 AM – Wrap-Up and Door Prizes \nSpeakers’ Bios\nBrad Nelson\, Ph.D. \nDistinguished Scientist\, \nScientific Director\, Immunotherapy Program\, \nBritish Columbia Cancer Research Institute \nVictoria BC\, Canada \nDr. Nelson is a native of Vancouver\, Canada. He received his B.Sc. from the University of British Columbia in 1987 and Ph.D. from the University of California at Berkeley in 1991. He completed postdoctoral training with Dr. Phil Greenberg and held faculty positions at the Fred Hutchinson Cancer Research Center and University of Washington in Seattle. In 2003\, he became the founding Director of BC Cancer’s Deeley Research Centre in Victoria BC. He is a Professor of Medical Genetics at the University of British Columbia and a Professor of Biochemistry/Microbiology at the University of Victoria. He holds the Lynda and Murray Farmer Immunotherapy Research Chair at BC Cancer and is a Fellow of the Royal Society of Canada. Dr. Nelson’s lab uses genomic and molecular approaches to study the immune response to cancer. As Scientific Director of BC Cancer’s Immunotherapy Program\, he is co-leading a phase I/II clinical trials program focused on engineered T cell therapies for lymphoid and gynecological cancers. Dr. Nelson is also a co-founder and CEO of Innovakine Therapeutics Inc\, which is using protein and cell engineering approaches to improve the efficacy and safety of cell-based therapies. He has played the guitar since he was a kid and is currently working his way (very slowly) through music of the Baroque era. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/deciphering-and-re-engineering-the-immune-response-to-cancer/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/deciphering-and-re-engineering-the-immune-response-to-cancer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260521T160000
DTEND;TZID=America/Los_Angeles:20260521T190000
DTSTAMP:20260617T215551
CREATED:20260416T155943Z
LAST-MODIFIED:20260416T155943Z
UID:10001065-1779379200-1779390000@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-sd-may21/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SD-Web-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260519
DTSTAMP:20260617T215551
CREATED:20260403T214343Z
LAST-MODIFIED:20260403T214343Z
UID:10001052-1779062400-1779148799@www.califesciences.org
SUMMARY:Healthy Lungs CA Advocacy Day
DESCRIPTION:Reducing the burden of lung cancer and COPD among at-risk and underserved communities. \nJoin colleagues from across the state to educate policymakers on efforts to improve lung health\, expand early detection and screenings\, and promote healthy environments. \nAdvocacy Day Program & Lunch\n9:30 AM – 1:00 PM \nPrelude Kitchen \n1117 11th Street\, Sacramento\, CA 95814 \nLegislative Meetings\n1:30 PM – 5:00 PM \nCapitol Annex Swing Space \n1021 O St.\, Sacramento\, CA 95814 \nReception\n5:00 PM – 6:30 PM \nPrelude Kitchen \n1117 11th Street\, Sacramento\, CA 95814 \nREGISTER» \nVIEW FLYER» \n 
URL:https://www.califesciences.org/event/healthy-lungs-ca-advocacy-day/
LOCATION:Sacramento\, CA\, Sacramento\, CA\, 95814\, United States
CATEGORIES:Advocacy & Government Relations,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260515T183000
DTEND;TZID=America/Los_Angeles:20260515T223000
DTSTAMP:20260617T215551
CREATED:20260330T161749Z
LAST-MODIFIED:20260512T213350Z
UID:10001048-1778869800-1778884200@www.califesciences.org
SUMMARY:Curebound Concert for Cures Featuring P!NK
DESCRIPTION:Since bursting onto the scene in 2000\, P!NK has built a career defined by fearless honesty\, extraordinary live shows\, and a refusal to fit a mold. Across nine studio albums and a greatest hits collection\, she’s sold over 60 million albums worldwide\, won three Grammy Awards (and 21 nominations)\, earned 15 Top 10 hits on the Billboard Hot 100 (including four #1’s)\, and a 2026 Rock & Roll Hall of Fame nominee. A trailblazer and passionate advocate for the cause she holds dear\, P!NK continues to evolve – staying true to herself and inspiring millions to do the same. \nDon’t miss an unforgettable night of P!NK’s full\, high-flying concert experience and be a part of this one-night-only event supporting lifesaving cancer research. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/curebound-concert-for-cures-2026/
LOCATION:Petco Park\, 100 Park Blvd\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260515T083000
DTEND;TZID=America/Los_Angeles:20260515T170000
DTSTAMP:20260617T215551
CREATED:20260327T183440Z
LAST-MODIFIED:20260327T183440Z
UID:10001045-1778833800-1778864400@www.califesciences.org
SUMMARY:Reimagining Science Education
DESCRIPTION:Science is evolving—is the way we train the next generation of experts keeping pace? 🧬📖 \nDigital Science\, Macmillan Learning\, Springer Nature\, and Scientific American are hosting a joint summit in San Francisco to tackle the evolution of the scientific workforce. This isn’t just a conversation for educators; it’s a vital touchpoint for industry leaders and innovators looking to influence the digital transformation of STEM. \n🗓️ May 15\, 2026 \n📍 SHACK15\, San Francisco 🌉 \n🔗 Register today: https://explore.macmillanlearning.com/reimagining-science-education-summit/ \nHosted by:
URL:https://www.califesciences.org/event/reimagining-science-education/
LOCATION:SHACK15\, Ferry Building\, 1\, Suite 201\, San Francisco\, CA\, 94111\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260514T080000
DTEND;TZID=America/Los_Angeles:20260514T173000
DTSTAMP:20260617T215551
CREATED:20260407T200853Z
LAST-MODIFIED:20260407T200853Z
UID:10001056-1778745600-1778779800@www.califesciences.org
SUMMARY:Small Molecule Preclinical Development and IND Filing: Nuts\, Bolts and Best Practices
DESCRIPTION:Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives\, expectations\, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often\, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed\, and this can lead to significant delays in clinical development. Additionally\, the regulatory environment is changing as rapidly as the industry. Therefore\, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety\, PK\, CMC\, and clinical plan is paramount. \nBelow are the topics to be covered: \n\n\n\nOverview of preclinical development and IND filing for small molecules\nKey preclinical studies required (Safety\, DMPK & CMC)\nClinical Development plans\n\n\n\n\nRegulatory strategie\nInteracting with regulatory agencies\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/small-molecule-preclinical-development-2/
LOCATION:Hilton San Diego/Del Mar\, 15575 Jimmy Durante Blvd\, Del Mar\, CA\, 92014\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260513T110000
DTEND;TZID=America/Los_Angeles:20260513T120000
DTSTAMP:20260617T215551
CREATED:20260407T202730Z
LAST-MODIFIED:20260407T202730Z
UID:10001058-1778670000-1778673600@www.califesciences.org
SUMMARY:Resolving Target Biology and Compound MOA at Scale: Enabling AI to Chat with Cells on the BioGPU Runtime
DESCRIPTION:Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. \nTargets and compounds advance without clear biological understanding\, leading to failure. \nAI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution. \nStatic data\, including omics\, cannot capture cellular biology in action\, where pathways interact and drive disease. \nWithout experimental access to biology inside cells at AI scale and speed\, target biology and compound MOA remain only partially understood. \nA new paradigm brings cellular biology directly into AI: BioGPU\, the biology-resolution runtime for AI. Introducing visual computing — a high-content\, pathway-level imaging experimental modality in cells at scale\, capturing biology in action. \nThis generates disease biology models of pathway and network activity in real cells. \nThrough the BioGPU agent\, AI models chat with cells\, operating on these models at runtime in a continuous loop of hypothesis\, experiments\, and refinement to: \n\nResolve target biology — what targets do and how they are regulated\, enabling causal targets to advance and weak targets to be killed\nResolve compound MOA\, how compounds modulate the system\, including pathway and off-target effects\n\nYou will see this in rheumatoid arthritis and ALS case studies\, where BioGPU connects to frontier AI systems\, ChatGPT and Gemini AI co-scientists\, operating on the BioGPU models at runtime to test and refine hypotheses\, deprioritize inactive pathways\, surface novel mechanisms and high-confidence targets. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resolving-target-biology-and-compound-moa-at-scale/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/resolving-target-biology-and-compound-moa-at-scale/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T084500
DTEND;TZID=America/Los_Angeles:20260511T173000
DTSTAMP:20260617T215551
CREATED:20260316T151719Z
LAST-MODIFIED:20260316T151719Z
UID:10001043-1778489100-1778520600@www.califesciences.org
SUMMARY:Formulation Development of Proteins and Antibodies: Fundamentals of Liquid Formulation\, High-Dose Delivery\, Non-Aqueous Formulations\, and GI Delivery
DESCRIPTION:Developing biopharmaceutical formulations that offer maximum patient convenience without sacrificing safety and efficacy for entities such as mAbs\, antibody drug conjugates\, and Fc-conjugates among others is increasingly complex.. Many drugs now require doses for subcutaneous delivery beyond what can be achieved with a 1 mL injection of an aqueous formulation. A significant hurdle in meeting this need is achieving the high drug concentrations required for these doses. \nThis workshop is structured to first provide an overview of pharmaceutical development. It will then showcase successful strategies across various areas\, including developability assessments\, surfactant use\, achieving high-dose delivery via non-aqueous suspensions\, and enabling the gastrointestinal delivery of biopharmaceuticals. The event will conclude with a discussion focusing on intellectual property within the drug product development landscape. \nThe workshop will cover the following key areas in pharmaceutical development of biopharmaceuticals: \n\nStrategies for Success: Successful approaches for molecule design\, developability assessments\, formulation design and minimizing surfactant degradation will be detailed.\nNew Technologies: An overview of novel technologies enabling high concentration\, high dose\, and gastrointestinal delivery.\nIntellectual Property: A summary of the intellectual property landscape relevant to biopharmaceutical drug product development.\n\nKey Topics\n\nAntibody engineering\nPharmaceutical development roadmap\nSurfactant selection and degradation mitigation\nDevelopability assessment for high concentration biologics\nHigh concentration antibody landscape\nNovel strategies for achieving ultra high concentrations through non-aqueous suspensions\nGastrointestinal delivery of biologics\nIntellectual property landscape for biologics drug product development\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/formulation-development-of-proteins-and-antibodies/
LOCATION:Kilroy Oyster Point\, 357 Oyster Point Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260508T113000
DTEND;TZID=America/Los_Angeles:20260508T133000
DTSTAMP:20260617T215551
CREATED:20260407T200002Z
LAST-MODIFIED:20260407T200002Z
UID:10001054-1778239800-1778247000@www.califesciences.org
SUMMARY:Highlights of 2025 FDA Drug Approvals
DESCRIPTION:In this presentation\, the speakers will summarize the 2025 cohort of new drugs approved by the FDA. Statistics on the overall cohort will be discussed\, followed by a short summary of key features of approved drugs. The speakers will also highlight case studies with interesting discovery and development stories. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/highlights-of-2025-fda-drug-approvals/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/highlights-of-2025-fda-drug-approvals/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T180000
DTEND;TZID=America/Los_Angeles:20260507T223000
DTSTAMP:20260617T215551
CREATED:20260303T204206Z
LAST-MODIFIED:20260303T204206Z
UID:10001031-1778176800-1778193000@www.califesciences.org
SUMMARY:Battle of the Bio/Tech Bands
DESCRIPTION:The Battle of the BioTech Bands is heading West! After an incredible run in Boston—including our milestone 10th anniversary this May and over $1.5 million raised since inception—we’re excited to grow even bigger. We’re expanding our reach with a brand-new West Coast battle. \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/battle-of-the-bio-tech-bands-2026/
LOCATION:Belly Up Tavern\, 143 S Cedros Ave\, Solona Beach\, CA\, 92075
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T160000
DTEND;TZID=America/Los_Angeles:20260507T190000
DTSTAMP:20260617T215551
CREATED:20260416T155202Z
LAST-MODIFIED:20260416T155820Z
UID:10001064-1778169600-1778180400@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-ssf-may7/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SF-Web-Card-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T190000
DTEND;TZID=America/Los_Angeles:20260506T210000
DTSTAMP:20260617T215551
CREATED:20260422T183703Z
LAST-MODIFIED:20260422T183703Z
UID:10001071-1778094000-1778101200@www.califesciences.org
SUMMARY:AI x Drug Discovery | SynBioBeta Mixer
DESCRIPTION:Exclusive mixer following the SynBioBeta main stage — an evening built for the vanguard of the TechBio ecosystem.\nIf you’re a founder\, investor\, or pharma partner working at the intersection of AI and biology\, come go beyond the panel and into deeper conversations on: \n→ Intelligent molecules \n→ Sequence design \n→ Programmable therapeutics \nYou’ll be in the room with SynBioBeta panelists\, active VCs\, biotech engineers\, research scientists\, and startup founders — in an elevated\, relaxed setting built for meaningful connection\, not name-tag small talk. \n🤝 Proudly partnering with SynBioBeta — friends of our AI x biotech community get an exclusive discount pass to the summit: https://www.syntheticbiologysummit.com/tickets/magnet \nCo-hosted with my partners Charleston Wong\, Vincent Song\, and Mickey Makhija\, alongside our organizing communities: \n\nMagnet Ventures — AI-driven biotech investment\, focused on computational drug discovery and therapeutic delivery\nTech Brews — 2\,000+ global founders & innovators across healthtech\, biotech\, and life sciences\nTechBio Transformers — scientists\, PMs\, computational biologists\, and engineers working at the biology x software x AI frontier\n\nHuge thanks to our sponsors: \n\nCornucopia Bio — infrastructure for self-driving labs\nMorrison Foerster (MoFo) — global life sciences & tech law firm\nSingapore Global Network — a 220k+ global professional community\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/ai-x-drug-discovery-synbiobeta-mixer/
LOCATION:Selva\, 44 S Almaden Ave\, San Jose\, CA\, 95113\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T110000
DTEND;TZID=America/Los_Angeles:20260506T120000
DTSTAMP:20260617T215551
CREATED:20260407T202955Z
LAST-MODIFIED:20260407T202955Z
UID:10001059-1778065200-1778068800@www.califesciences.org
SUMMARY:The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma
DESCRIPTION:Is your AI trustworthy? 🤖🔬 \nA ‘scientific content crisis’ is leaving 27% of life science professionals unable to trace the data powering their AI. This isn’t just a technical hurdle—it’s a regulatory risk. \nJoin our upcoming webinar with Fierce Pharma “The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma\,” to learn how to move from aspiration to full implementation. \nWe’ll dive into:\n✅ The Governance Gap: Moving to a traceable\, audit-ready data pedigree.\n✅ Knowledge Graphs: Creating the infrastructure to make internal data AI-ready.\n✅ Grounded AI: Using neuro-symbolic approaches to eliminate LLM hallucinations. \n📅 Date: Wednesday\, May 6\, 2026 | 🕚 Time: 11:00 AM ET \nDon’t let your AI projects stall at the pilot stage. Register now to build a foundation of verified evidence \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-foundation-for-trustworthy-ai-the-fair-data-playbook-for-pharma/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-foundation-for-trustworthy-ai-the-fair-data-playbook-for-pharma/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260505T110000
DTEND;TZID=America/Los_Angeles:20260505T140000
DTSTAMP:20260617T215551
CREATED:20260316T151403Z
LAST-MODIFIED:20260316T151403Z
UID:10001042-1777978800-1777989600@www.califesciences.org
SUMMARY:R&D Vendor Discovery Day - San Diego
DESCRIPTION:Join Scientist.com on May 5th for our annual San Diego Vendor Discovery Day! Discover novel technologies\, network with industry professionals\, and enjoy a complimentary lunch with fellow San Diego-based biopharma professionals. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/rd-vendor-discovery-day-san-diego/
LOCATION:Farmer & The Seahorse\, 10996 Torreyana Rd Ste 240\, San Diego\,\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260508
DTSTAMP:20260617T215551
CREATED:20260319T202656Z
LAST-MODIFIED:20260319T202656Z
UID:10001044-1777852800-1778198399@www.califesciences.org
SUMMARY:SynBioBeta 2026: The Global Synthetic Biology Partnering Summit
DESCRIPTION:Every May for the past 14 years\, more than 2\,000 investors\, Fortune 500 executives\, founders\, and scientists have gathered at SynBioBeta to make deals\, start partnerships\, and shape what the next 6–12 months of the life sciences ecosystem will look like. \nThis year’s program spans 6 frontier areas shaping the future of biology: \nAI × Biology\nFoundation models\, multimodal biological AI\, predictive design for drugs\, materials\, and sustainable systems. \nHuman Health & Longevity\nAI-powered drug discovery\, cell and gene therapies\, diagnostics\, and engineered therapeutics. \nPlanetary Health & Sustainability\nFood and agriculture\, climate tech\, sustainable materials\, and bio-enabled manufacturing. \nBiomanufacturing at Scale\nContinuous fermentation\, scalable bioprocessing\, and real-time monitoring for cost-competitive production. \nTools\, Tech & Platforms\nSequencing\, synthesis\, genome editing\, automation\, cloud labs\, and AI-driven discovery platforms. \nThe Business of Biology\nCommercialization\, market strategy\, funding\, partnerships\, regulatory\, and IP strategy. \nThe stage will feature leaders such as David Sinclair\, Pardis Sabeti\, Drew Endy\, and Emily Leproust\, alongside executives and research leaders from organizations including: \nDARPA • ARPA-H • U.S. Department of Energy \nIndustry leaders including: \nProcter & Gamble • Unilever • Mars \nAnd global biopharma companies including: \nAstraZeneca • GlaxoSmithKline • Novo Nordisk • Eli Lilly \n\nCLS members receive a 10% discount to attend the full conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nHosted by:
URL:https://www.califesciences.org/event/synbiobeta-2026/
LOCATION:150 West San Carlos Street\, 150 West San Carlos Street\, San Jose\, CA\, 95113\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T084500
DTEND;TZID=America/Los_Angeles:20260430T173000
DTSTAMP:20260617T215551
CREATED:20260401T221727Z
LAST-MODIFIED:20260401T221727Z
UID:10001051-1777538700-1777570200@www.califesciences.org
SUMMARY:Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies
DESCRIPTION:This symposium will highlight emerging strategies and practical considerations in drug metabolism\, bioanalysis\, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides\, peptides\, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. \nExpert speakers from industry will share real-world case studies and methodological advances addressing in vitro ADME characterization and innovative LC–MS bioanalytical strategies across a range of therapeutic modalities. Topics will include modality-specific challenges\, comparison of novel modalities with small molecules\, and lessons learned from both cleavable and non-cleavable ADC linker systems. \nThis event will provide valuable insights for scientists working in DMPK\, bioanalysis\, and translational research\, offering practical perspectives on how evolving analytical technologies are being applied to support drug discovery and development in a rapidly changing therapeutic landscape. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vendor-scientific-highlights-symposium/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T160000
DTEND;TZID=America/Los_Angeles:20260429T190000
DTSTAMP:20260617T215551
CREATED:20260427T161055Z
LAST-MODIFIED:20260427T161055Z
UID:10001072-1777478400-1777489200@www.califesciences.org
SUMMARY:Strategic R&D Partner Seminar
DESCRIPTION:PROGRAM HIGHLIGHTS\n\n4:00 PM Registration & Welcome\n4:20 PM Talk session\n\nAutomated Platform for Pharmaceutical Formulation Development\n\nKenan Pandza\, VP of R&D — Persist AI\n\n\nOne Vision\, Two Strategies: Integrated & Open-Platform Lab Automation\n\nAndy Sasaki\, GM R&D Center — Shimadzu Scientific Instruments\n\n\nFind the Needle in the Haystack with FAST Fluorescence Imaging\n\nJoerg Martini\, Assoc. Director — SRI International\n\n\nAI-Driven Culture Media Optimization for Biopharmaceuticals\n\nHirotaka Kuroda\, Senior Researcher — Shimadzu Corporation\n\n\n\n\n6:00 PM Networking & Poster Session\n\nPAT\, NAMs\, Particle Separation & more\n\n\n\nKEY TOPICS\nLab Automation • HPLC & LCMS & Analytics • Cell Culture AI • Fluorescence Imaging • Drug Formulation • PAT • Particle Separation • NAMs • Centrifugal Field-flow Fractionation • Pharma R&D \nIdeal for pharmaceutical scientists\, analytical chemists\, bioprocess engineers\, and life science researchers \nREGISTER»
URL:https://www.califesciences.org/event/strategic-rd-partner-seminar/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T070000
DTEND;TZID=America/Los_Angeles:20260429T093000
DTSTAMP:20260617T215551
CREATED:20260409T224039Z
LAST-MODIFIED:20260409T224039Z
UID:10001062-1777446000-1777455000@www.califesciences.org
SUMMARY:Obtaining Executive Roles
DESCRIPTION:Brought by: Hands On Learning (handscom.com) a specialist in leadership development and coaching for Life Sciences. \nJoin us in this interactive panel discussion with Q&A on practical tips\, guidance\, and candid lessons learned from Life Sciences and Technology executives. What you’ll learn / gain: \n– What it takes to obtain an executive-level role\n– Practical tips and guidance on how to get there\n– Gain direct exposure to industry executives\n– Grow your professional network \n$195.00 per person. Typically reimbursable by your organization. Contact info@handscom.com to learn more. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/obtaining-executive-roles/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/obtaining-executive-roles/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T070000
DTEND;TZID=America/Los_Angeles:20260429T080000
DTSTAMP:20260617T215551
CREATED:20260312T164850Z
LAST-MODIFIED:20260312T164850Z
UID:10001040-1777446000-1777449600@www.califesciences.org
SUMMARY:Rapid and flexible analytical characterization of oligonucleotides
DESCRIPTION:Therapeutic oligonucleotides (ASOs\, siRNA and conjugates) present analytical challenges due to their structural diversity and chemical modifications. In early discovery\, robust UV×MS purity assessment and impurity profiling are essential for both crude oligonucleotide libraries prior to early screening and purified batches prior to advanced assays. \nHere\, we present a streamlined LC–UV–MS platform comprising two methods paired with (semi-)automated data processing to increase analytical throughput and accelerate decision-making. First\, a flexible characterization method provides chromatographic separation and UV×MS purity/impurity analysis for purified ASOs\, siRNA and conjugates\, with semi-automated processing and automated reporting enabled by the Byos Oligo App. Second\, a high-throughput method delivers online desalting\, rapid MS fingerprinting\, purity analysis and impurity-class profiling for crude ASO and siRNA single‑strand libraries at scale (hundreds per day). \nTogether\, these methods provide a fast\, scalable and fit‑for‑purpose framework for oligonucleotide characterization in early drug discovery. \nKey takeaways:\n\nFit‑for‑purpose LC–UV–MS workflows We developed two analytical methods\, one for detailed characterization of purified batches and one for high‑throughput screening of crude libraries\, covering early discovery needs.\n(Semi-)automated data analysis We integrated data analysis tools\, such as the Byos Oligo workflow\, to enable semi‑automated UV×MS purity determination and impurity assignment with automated reporting\, reducing manual effort and variability.\nStandardized reporting We implemented standardized outputs to deliver consistent purity/impurity metrics for oligonucleotides\, improving comparability across libraries and individual samples.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/rapid-and-flexible-analytical-characterization-of-oligonucleotides-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/rapid-and-flexible-analytical-characterization-of-oligonucleotides-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260501
DTSTAMP:20260617T215551
CREATED:20260213T182236Z
LAST-MODIFIED:20260213T182236Z
UID:10001009-1777420800-1777593599@www.califesciences.org
SUMMARY:Pharma Partnering US Summit 2026
DESCRIPTION:The Pharma Partnering Summit is an exclusive Life Sciences Industry event\, with the aim to help companies expand their network and put together licensing deals\, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing\, Alliance Management\, Research Collaborations\, M&A and Investment. In addition to identifying products and partners as well as investors\, the forum also serves to disseminate knowledge through expert speakers\, for the best practices in the field of industry partnerships. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pharma-partnering-us-summit-2026/
LOCATION:Hilton Garden Inn – San Diego/Del Mar\, 3939 Ocean Bluff Ave\, San Diego\, CA\, 92130\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
END:VCALENDAR